UP0 Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Ultragenyx Pharmaceutical Inc

Watchlist Manager

Watchlist

Price: 21.43 EUR -6.74% Market Closed

Market Cap: €1.9B

U	Ultragenyx Pharmaceutical Inc F:UP0	US
	WPP PLC LSE:WPP	UK
S	Siemens Energy AG XMUN:ENR	DE
A	ANSYS Inc F:AKX	US
B	Baloise Holding AG XMUN:BLON	CH
E	Entergy Corp F:ETY	US
F	Flex Ltd F:FXI	SG
	Deckers Outdoor Corp NYSE:DECK	US
T	Teradyne Inc DUS:TEY	US
C	Continental AG F:CON	DE

Profitability Summary

Ultragenyx Pharmaceutical Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

83%

Strong 3Y Average Gross Margin

86%

Declining Gross Margin

91% > 83%

Negative Operating Margin

-74%

Negative 3Y Average Operating Margin

-101%

Operating Margin is Increasing

-167% > -74%

Negative Net Margin

-82%

Negative 3Y Average Net Margin

-108%

Net Margin is Increasing

-179% > -82%

Negative Free Cash Flow Margin

-69%

Negative 3Y Average Free Cash Flow Margin

-90%

Free Cash Flow Margin is Increasing

-137% > -69%

Exceptional ROE

839%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-68%

ROIC is Increasing

-93% > -62%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

83%

Strong 3Y Average Gross Margin

86%

Declining Gross Margin

91% > 83%

Negative Operating Margin

-74%

Negative 3Y Average Operating Margin

-101%

Operating Margin is Increasing

-167% > -74%